Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
50 hedge funds and large institutions have $44.5M invested in Vigil Neuroscience in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 9 closing their positions.
16% more capital invested
Capital invested by funds: $38.4M → $44.5M (+$6.11M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.69% less ownership
Funds ownership: 55.32% → 53.63% (-1.7%)
2% less funds holding
Funds holding: 51 → 50 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$4.94M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$2.68M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.96M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$1.59M |
| 5 |
6CM
683 Capital Management
New York
|
+$763K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.56M |
| 2 |
Millennium Management
New York
|
-$741K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$561K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$530K |
| 5 |
Goldman Sachs
New York
|
-$451K |
VIGL Hedge Fund Activity: Q1 2025 in Review
50 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2025, worth a combined $44.5M — up 16% from $38.4M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VIGL and 8 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 13 added.
The largest buyer was BVF Inc, adding an estimated $4.94M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.56M sold.
- 50 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2025, down from 51 in Q4 2024.
- Funds reported $44.5M of Vigil Neuroscience stock for Q1 2025, up 16% quarter-over-quarter.
- 8 funds opened new Vigil Neuroscience positions in Q1 2025 and 9 closed out, a net change of -1 holder.
- The largest Vigil Neuroscience buyer in Q1 2025 was BVF Inc, an estimated $4.94M added.
- The largest Vigil Neuroscience seller in Q1 2025 was Citadel Advisors, an estimated $2.56M sold.
Based on aggregated 13F filings for Q1 2025.